| The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample W Lawn, M Barratt, M Williams, A Horne, A Winstock Journal of Psychopharmacology 28 (8), 780-788, 2014 | 141 | 2014 |
| Application of Fragment‐Based Screening to the Design of Inhibitors of Escherichia coli DsbA LA Adams, P Sharma, B Mohanty, OV Ilyichova, MD Mulcair, ML Williams, ... Angewandte Chemie 127 (7), 2207-2212, 2015 | 57 | 2015 |
| Guanidinium‐Type resonance stabilization and its biological implications. I. the guanidine and extended‐guanidine series ML Williams, JE Gready Journal of Computational Chemistry 10 (1), 35-54, 1989 | 49 | 1989 |
| Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm D Perkins, J Sarris, S Rossell, Y Bonomo, D Forbes, C Davey, D Hoyer, ... Australian & New Zealand Journal of Psychiatry 55 (12), 1127-1133, 2021 | 45 | 2021 |
| Rethinking therapeutic strategies for anorexia nervosa: insights from psychedelic medicine and animal models CJ Foldi, P Liknaitzky, M Williams, BJ Oldfield Frontiers in Neuroscience 14, 513366, 2020 | 44 | 2020 |
| Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein R Patil, A Laguerre, J Wielens, SJ Headey, ML Williams, MLR Hughes, ... ACS chemical biology 9 (11), 2526-2534, 2014 | 30 | 2014 |
| Experience of music used with psychedelic therapy: A rapid review and implications C O’Callaghan, DJ Hubik, J Dwyer, M Williams, M Ross Journal of music therapy 57 (3), 282-314, 2020 | 26 | 2020 |
| Rapid Elaboration of Fragments into Leads by X-ray Crystallographic Screening of Parallel Chemical Libraries (REFiLX) MR Bentley, OV Ilyichova, G Wang, ML Williams, G Sharma, WS Alwan, ... Journal of Medicinal Chemistry 63 (13), 6863-6875, 2020 | 24 | 2020 |
| Psilocybin-assisted therapy for depression: How do we advance the field? SE Meikle, P Liknaitzky, SL Rossell, M Ross, N Strauss, N Thomas, ... Australian & New Zealand Journal of Psychiatry 54 (3), 225-231, 2020 | 23 | 2020 |
| Determination of ligand binding modes in weak protein–ligand complexes using sparse NMR data B Mohanty, ML Williams, BC Doak, M Vazirani, O Ilyichova, G Wang, ... Journal of biomolecular NMR 66, 195-208, 2016 | 20 | 2016 |
| A ligand-induced structural change in fatty acid–binding protein 1 is associated with potentiation of peroxisome proliferator–activated receptor α agonists R Patil, B Mohanty, B Liu, IR Chandrashekaran, SJ Headey, ML Williams, ... Journal of Biological Chemistry 294 (10), 3720-3734, 2019 | 19 | 2019 |
| Should Australian psychology consider enhancing psychotherapeutic interventions with psychedelic drugs? A call for research S Bright, M Williams Australian Psychologist 53 (6), 467-476, 2018 | 14 | 2018 |
| Structural and biochemical insights into the disulfide reductase mechanism of DsbD, an essential enzyme for neisserial pathogens RP Smith, B Mohanty, S Mowlaboccus, JJ Paxman, ML Williams, ... Journal of Biological Chemistry 293 (43), 16559-16571, 2018 | 12 | 2018 |
| Australia should be initiating a psychedelic research program: What are the barriers? N Strauss, SJ Bright, ML Williams Australian & New Zealand Journal of Psychiatry 50 (11), 1036-1037, 2016 | 11 | 2016 |
| International pediatric COVID-19 severity over the course of the pandemic Y Zhu, FJ Almeida, JK Baillie, AC Bowen, PN Britton, ME Brizuela, ... JAMA pediatrics 177 (10), 1073-1084, 2023 | 10 | 2023 |
| NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide–dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei S Nebl, WS Alwan, ML Williams, G Sharma, A Taylor, BC Doak, KL Wilde, ... Journal of Biomolecular NMR 74, 595-611, 2020 | 9 | 2020 |
| Should addiction researchers be interested in psychedelic science? S Bright, M Williams, D Caldicott Drug and alcohol review 36 (3), 285-287, 2017 | 7 | 2017 |
| Translating psychedelic therapies from clinical trials to community clinics: building bridges and addressing potential challenges ahead ML Williams, D Korevaar, R Harvey, PB Fitzgerald, P Liknaitzky, ... Frontiers in Psychiatry 12, 737738, 2021 | 6 | 2021 |
| Purification and characterization of adenovirus core protein VII: a histone-like protein that is critical for adenovirus core formation G Sharma, N Moria, M Williams, B Krishnarjuna, CW Pouton Journal of General Virology 98 (7), 1785-1794, 2017 | 6 | 2017 |
| Effective targeted and community HIV MW Ross, ML Williams STD, 2002 | 5 | 2002 |
